Control of hospital endemicity of multiple-drug-resistant Acinetobacter baumannii ST457 with directly observed hand hygiene

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 34, Issue 4, 2015, Pages 713-718

  Cheng, V C C ^a   Chen, J H K ^a   Poon, R W S ^a   Lee, W M ^a   So, S Y C ^a   Wong, S C Y ^a   Chau, P H ^b   Yip, C C Y ^a   Wong, S S Y ^a   Chan, J F W ^a   Hung, I F N ^a   Ho, P L ^a   Yuen, K Y ^a  

^a QUEEN MARY HOSPITAL   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE INHIBITOR; CARBAPENEM; CEFOPERAZONE PLUS SULBACTAM; CEFTAZIDIME; CEPHALOSPORIN; CILASTATIN PLUS IMIPENEM; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; QUINOLONE DERIVATIVE; SULTAMICILLIN; TIMENTIN; TOBRAMYCIN;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTION; ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM ISOLATE; CHILD; CONFIDENCE INTERVAL; CONTROLLED STUDY; ENDEMIC DISEASE; FEMALE; HAND WASHING; HOSPITAL; HOSPITAL ADMISSION; HUMAN; INCIDENCE; INFECTION CONTROL; LOGISTIC REGRESSION ANALYSIS; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MEAL; MEDICINE; MULTIDRUG RESISTANCE; MULTIPLE DRUG RESISTANT ACINETOBACTER BAUMANNII; PRIORITY JOURNAL; RISK FACTOR; ACINETOBACTER INFECTIONS; BACTEREMIA; CROSS INFECTION; DRUG EFFECTS; ENDEMIC DISEASES; HONG KONG; INFANT; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; PRESCHOOL CHILD; PROCEDURES; VERY ELDERLY; YOUNG ADULT;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BACTEREMIA; CHILD; CHILD, PRESCHOOL; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ENDEMIC DISEASES; FEMALE; HAND HYGIENE; HONG KONG; HOSPITALS; HUMANS; INCIDENCE; INFANT; INFECTION CONTROL; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 84925497660     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-014-2281-x     Document Type: Article

References (29)

1. Kramer A, Schwebke I, Kampf G (2006) How long do nosocomial pathogens persist on inanimate surfaces? A systematic review. BMC Infect Dis 6:130
2. Gkrania-Klotsas E, Hershow RC (2006) Colonization or infection with multidrug-resistant Acinetobacter baumannii may be an independent risk factor for increased mortality. Clin Infect Dis 43(9):1224–1225
3. Mendes RE, Spanu T, Deshpande L, Castanheira M, Jones RN, Fadda G (2009) Clonal dissemination of two clusters of Acinetobacter baumannii producing OXA-23 or OXA-58 in Rome, Italy. Clin Microbiol Infect 15(6):588–592
4. Landman D, Quale JM, Mayorga D, Adedeji A, Vangala K, Ravishankar J, Flores C, Brooks S (2002) Citywide clonal outbreak of multiresistant Acinetobacter baumannii and Pseudomonas aeruginosa in Brooklyn, NY: the preantibiotic era has returned. Arch Intern Med 162(13):1515–1520
5. Siau H, Yuen KY, Ho PL, Wong SS, Woo PC (1999) Acinetobacter bacteremia in Hong Kong: prospective study and review. Clin Infect Dis 28(1):26–30
6. Ho PL, Ho AY, Chow KH, Lai EL, Ching P, Seto WH (2010) Epidemiology and clonality of multidrug-resistant Acinetobacter baumannii from a healthcare region in Hong Kong. J Hosp Infect 74(4):358–364
7. Ho PL, Ho AY, Chow KH, Cheng VC (2010) Surveillance for multidrug-resistant Acinetobacter baumannii: a lesson on definitions. Int J Antimicrob Agents 36(5):469–471
8. Falagas ME, Koletsi PK, Bliziotis IA (2006) The diversity of definitions of multidrug-resistant (MDR) and pandrug-resistant (PDR) Acinetobacter baumannii and Pseudomonas aeruginosa. J Med Microbiol 55(Pt 12):1619–1629
9. Bartual SG, Seifert H, Hippler C, Luzon MA, Wisplinghoff H, Rodríguez-Valera F (2005) Development of a multilocus sequence typing scheme for characterization of clinical isolates of Acinetobacter baumannii. J Clin Microbiol 43(9):4382–4390
10. Cheng VC, Tai JW, Chan WM, Lau EH, Chan JF, To KK, Li IW, Ho PL, Yuen KY (2010) Sequential introduction of single room isolation and hand hygiene campaign in the control of methicillin-resistant Staphylococcus aureus in intensive care unit. BMC Infect Dis 10:263
11. Ng TM, Teng CB, Lye DC, Apisarnthanarak A (2014) A multicenter case–case control study for risk factors and outcomes of extensively drug-resistant Acinetobacter baumannii bacteremia. Infect Control Hosp Epidemiol 35(1):49–55
12. Kim SB, Min YH, Cheong JW, Kim JS, Kim SJ, Ku NS, Jeong SJ, Han SH, Choi JY, Song YG, Kim JM (2014) Incidence and risk factors for carbapenem- and multidrug-resistant Acinetobacter baumannii bacteremia in hematopoietic stem cell transplantation recipients. Scand J Infect Dis 46(2):81–88
13. Jung JY, Park MS, Kim SE, Park BH, Son JY, Kim EY, Lim JE, Lee SK, Lee SH, Lee KJ, Kang YA, Kim SK, Chang J, Kim YS (2010) Risk factors for multi-drug resistant Acinetobacter baumannii bacteremia in patients with colonization in the intensive care unit. BMC Infect Dis 10:228
14. Anunnatsiri S, Tonsawan P (2011) Risk factors and clinical outcomes of multidrug-resistant Acinetobacter baumannii bacteremia at a university hospital in Thailand. Southeast Asian J Trop Med Public Health 42(3):693–703
15. Shih MJ, Lee NY, Lee HC, Chang CM, Wu CJ, Chen PL, Ko NY, Ko WC (2008) Risk factors of multidrug resistance in nosocomial bacteremia due to Acinetobacter baumannii: a case–control study. J Microbiol Immunol Infect 41(2):118–123
16. Li Y, Pan C, Zhao Z, Zhao Z, Chen H, Lu W (2013) Effects of a combination of amlodipine and imipenem on 42 clinical isolates of Acinetobacter baumannii obtained from a teaching hospital in Guangzhou, China. BMC Infect Dis 13:548
17. Cheng VC, Chan JF, Lau EH, Yam WC, Ho SK, Yau MC, Tse EY, Wong AC, Tai JW, Fan ST, Ho PL, Yuen KY (2011) Studying the transmission dynamics of meticillin-resistant Staphylococcus aureus in Hong Kong using spa typing. J Hosp Infect 79(3):206–210
18. Cheng VC, Tai JW, Wong ZS, Chen JH, Pan KB, Hai Y, Ng WC, Chow DM, Yau MC, Chan JF, Wong SC, Tse H, Chan SS, Tsui KL, Chan FH, Ho PL, Yuen KY (2013) Transmission of methicillin-resistant Staphylococcus aureus in the long term care facilities in Hong Kong. BMC Infect Dis 13:205
19. Cheng VC, Yam WC, Lam OT, Tsang JL, Tse EY, Siu GK, Chan JF, Tse H, To KK, Tai JW, Ho PL, Yuen KY (2011) Clostridium difficile isolates with increased sporulation: emergence of PCR ribotype 002 in Hong Kong. Eur J Clin Microbiol Infect Dis 30(11):1371–1381
20. Donskey CJ, Chowdhry TK, Hecker MT, Hoyen CK, Hanrahan JA, Hujer AM, Hutton-Thomas RA, Whalen CC, Bonomo RA, Rice LB (2000) Effect of antibiotic therapy on the density of vancomycin-resistant enterococci in the stool of colonized patients. N Engl J Med 343(26):1925–1932
21. Cheng VC, Li IW, Wu AK, Tang BS, Ng KH, To KK, Tse H, Que TL, Ho PL, Yuen KY (2008) Effect of antibiotics on the bacterial load of meticillin-resistant Staphylococcus aureus colonisation in anterior nares. J Hosp Infect 70(1):27–34
22. Cheng VC, Tai JW, Chau PH, Chen JH, Yan MK, So SY, To KK, Chan JF, Wong SC, Ho PL, Yuen KY (2014) Minimal intervention for controlling nosocomial transmission of methicillin-resistant Staphylococcus aureus in resource limited setting with high endemicity. PLoS One 9(6):e100493
23. Cheng VC, Tai JW, Ng ML, Chan JF, Wong SC, Li IW, Chung HP, Lo WK, Yuen KY, Ho PL (2012) Extensive contact tracing and screening to control the spread of vancomycin-resistant Enterococcus faecium ST414 in Hong Kong. Chin Med J (Engl) 125(19):3450–3457
24. Cheng VC, Chan JF, Wong SC, Chen JH, Tai JW, Yan MK, Kwan GS, Tse H, To KK, Ho PL, Yuen KY (2013) Proactive infection control measures to prevent nosocomial transmission of carbapenem-resistant Enterobacteriaceae in a non-endemic area. Chin Med J (Engl) 126(23):4504–4509
25. Cheng VC, Tai JW, Chen JH, So SY, Ng WC, Hung IF, Leung SS, Wong SC, Chan TC, Chan FH, Ho PL, Yuen KY (2014) Proactive infection control measures to prevent nosocomial transmission of vancomycin-resistant enterococci in Hong Kong. J Formos Med Assoc 113(10):734–741
26. Cheng VC, To KK, Li IW, Tang BS, Chan JF, Kwan S, Mak R, Tai J, Ching P, Ho PL, Seto WH (2009) Antimicrobial stewardship program directed at broad-spectrum intravenous antibiotics prescription in a tertiary hospital. Eur J Clin Microbiol Infect Dis 28(12):1447–1456
27. Tacconelli E, Cataldo MA, Dancer SJ, De Angelis G, Falcone M, Frank U, Kahlmeter G, Pan A, Petrosillo N, Rodríguez-Baño J, Singh N, Venditti M, Yokoe DS, Cookson B; European Society of Clinical Microbiology (2014) ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients. Clin Microbiol Infect 20(Suppl 1):1–55
28. Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, Harbarth S, Hindler JF, Kahlmeter G, Olsson-Liljequist B, Paterson DL, Rice LB, Stelling J, Struelens MJ, Vatopoulos A, Weber JT, Monnet DL (2012) Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 18(3):268–281
29. Batirel A, Balkan II, Karabay O, Agalar C, Akalin S, Alici O, Alp E, Altay FA, Altin N, Arslan F, Aslan T, Bekiroglu N, Cesur S, Celik AD, Dogan M, Durdu B, Duygu F, Engin A, Engin DO, Gonen I, Guclu E, Guven T, Hatipoglu CA, Hosoglu S, Karahocagil MK, Kilic AU, Ormen B, Ozdemir D, Ozer S, Oztoprak N, Sezak N, Turhan V, Turker N, Yilmaz H (2014) Comparison of colistin–carbapenem, colistin–sulbactam, and colistin plus other antibacterial agents for the treatment of extremely drug-resistant Acinetobacter baumannii bloodstream infections. Eur J Clin Microbiol Infect Dis 33(8):1311–1322